These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 38262085)

  • 1. Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy.
    Lombardi A; Villa S; Colaneri M; Scaglione G; Bai F; Varisco B; Bono V; Vena A; Dentone C; Russo C; Tettamanti M; Renisi G; Viero G; Azzarà C; Mantero M; Peyvandi F; Bassetti M; Marchetti G; Muscatello A; Nobili A; Gori A; Bandera A;
    J Infect Public Health; 2024 Mar; 17(3):467-473. PubMed ID: 38262085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.
    Hasseli R; Richter JG; Hoyer BF; Lorenz HM; Pfeil A; Regierer AC; Schmeiser T; Strangfeld A; Voll RE; Krause A; Reckert S; Gräßler A; Saar P; Kapelle A; Backhaus M; Blank N; Henes J; Osiek S; Knothe A; Hoese G; Brandt-Jürgens J; Maltzahn A; Specker C; Müller-Ladner U; Schulze-Koops H; ;
    RMD Open; 2023 Apr; 9(2):. PubMed ID: 37068915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection.
    Epaulard O; Abgrall S; Lefebvre M; Faucher JF; Michon J; Frentiu E; Blanchi S; Janssen C; Charbonnier G; Fresse A; Laurent S; Sandjakian L; Casez P; Mahamat A; Beraud G
    Clin Microbiol Infect; 2022 Dec; 28(12):1629-1635. PubMed ID: 35779764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey.
    Mediavilla JR; Lozy T; Lee A; Kim J; Kan VW; Titova E; Amin A; Zody MC; Corvelo A; Oschwald DM; Baldwin A; Fennessey S; Zuckerman JM; Kirn T; Chen L; Zhao Y; Chow KF; Maniatis T; Perlin DS; Kreiswirth BN
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
    Basso P; Negro C; Cegolon L; Larese Filon F
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals.
    Vo AD; La J; Wu JT; Strymish JM; Ronan M; Brophy M; Do NV; Branch-Elliman W; Fillmore NR; Monach PA
    JAMA Netw Open; 2022 Oct; 5(10):e2240037. PubMed ID: 36264571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital.
    Russo C; Tagliafico L; Labate L; Ponzano M; Mirabella M; Portunato F; Bellezza C; Mora S; Arboscello E; Monacelli F; Nencioni A; Signori A; Bruzzone B; Giacomini M; Dentone C; Bassetti M
    J Chemother; 2023 Dec; 35(8):730-736. PubMed ID: 37608747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Vaccination Status and Outcomes in Patients Admitted to the ICU With COVID-19.
    van Diepen S; McAlister FA; Chu LM; Youngson E; Kaul P; Kadri SS
    Crit Care Med; 2023 Sep; 51(9):1201-1209. PubMed ID: 37192450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Study of Vaccinated and Unvaccinated Hospitalised Patients: A Retrospective Population Study of 500 Hospitalised Patients with SARS-CoV-2 Infection in a Spanish Population of 220,000 Inhabitants.
    Ruiz-Giardin JM; Rivilla M; Mesa N; Morales A; Rivas L; Izquierdo A; Escribá A; San Martín JV; Bernal-Bello D; Madroñal E; Farfán AI; Guerrero M; Calderón R; Duarte MA; Piedrabuena SI; Toledano-Macías M; Satué JÁ; Marrero J; de Ancos CL; Frutos B; Cristóbal R; Soria G; Ayala-Larrañaga I; Carpintero L; de Hita M; Lara C; Llerena ÁR; García V; Jiménez R; García V; Saiz-Lou EM; Prieto S; González-Pereira N; Lechuga LA; Tarancón J; Gonzalo S;
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago.
    Moreno Echevarria F; Caputo M; Camp D; Reddy S; Achenbach CJ
    PLoS One; 2024; 19(8):e0302338. PubMed ID: 39102410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study.
    Md Yusof MY; Arnold J; Saleem B; Vandevelde C; Dass S; Savic S; Vital EM; Emery P
    Lancet Rheumatol; 2023 Feb; 5(2):e88-e98. PubMed ID: 36712951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
    Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
    Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the SARS-CoV-2 Vaccination in Preventing Severe Disease-Related Outcomes: A Population-Based Study in the Italian Province of Bolzano (South Tyrol).
    Lorenzon A; Palandri L; Uguzzoni F; Cristofor CD; Lozza F; Poluzzi R; Rizzi C; Bertoli P; Zerzer F; Righi E
    Int J Public Health; 2024; 69():1606792. PubMed ID: 38550269
    [No Abstract]   [Full Text] [Related]  

  • 15. Characteristics of COVID-19 vaccinated and unvaccinated patients admitted to Careggi University Hospital, Florence, Italy.
    Paggi R; Barbiero A; Manciulli T; Miftode A; Tilli M; Lagi F; Mencarini J; Borchi B; Pozzi M; Bartalesi F; Spinicci M; Martini L; Coppola A; Nozzoli C; Peris A; Bonizzoli M; Pieralli F; Bartoloni A; Zammarchi L
    Intern Emerg Med; 2023 Apr; 18(3):821-830. PubMed ID: 36853393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel.
    Maltezou HC; Gamaletsou MN; Giannouchos TV; Koukou DM; Karapanou A; Sourri F; Syrimi N; Lemonakis N; Peskelidou E; Papanastasiou K; Souliotis K; Lourida A; Panagopoulos P; Hatzigeorgiou D; Sipsas NV
    J Hosp Infect; 2023 Feb; 132():46-51. PubMed ID: 36473554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes.
    Bea S; Choi A; Kim JH; Cho YM; Choi WS; Jung J; Shin JY
    Diabetes Obes Metab; 2023 Sep; 25(9):2734-2742. PubMed ID: 37312652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EuCARE-hospitalised study protocol: a cohort study of patients hospitalised with COVID-19 in the EuCARE project.
    Hedberg P; Varisco B; Bai F; Sönnerborg A; Naucler P; Pfeifer N; Cozzi-Lepri A; Ceccherini-Silberstein F; Naumovas D; Drobniewski F; Jensen BO; Toscano C; Parczewski M; Quintanares GHR; Mwau M; Pinto JA; Incardona F; Mommo C; Marchetti G
    BMC Infect Dis; 2023 Oct; 23(1):690. PubMed ID: 37845624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risk of Hospitalization and Mortality After Breakthrough SARS-CoV-2 Infection by Vaccine Type: Observational Study of Medical Claims Data.
    Kshirsagar M; Nasir M; Mukherjee S; Becker N; Dodhia R; Weeks WB; Ferres JL; Richardson B
    JMIR Public Health Surveill; 2022 Nov; 8(11):e38898. PubMed ID: 36265135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Outcomes of Hospitalized Adult Patients With Breakthrough COVID-19 Infections: A Propensity-Score-Matched Observational Study.
    Niu J; Samuels S; Sareli C; Mayer D; Visbal A; Sareli AE
    Am J Epidemiol; 2024 Feb; 193(2):285-295. PubMed ID: 37823271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.